engine the biomarker company
- Company typePrivate
- Founded2008
- HeadquartersHennigsdorf, Germany
- Headcount—
- GTM typeB2B
- OfferingServices
engine the biomarker company firmographics
Firmographics- Name
- engine the biomarker company
- Legal name
- engine the biomarker company
- Website
- https://proteinarrays.bio
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Ownership category
- akta.pro rank
engine the biomarker company industry classification
Industry- Product category
- Proteomics and biomarker discovery services
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Biomarker Discovery & Validation (omics, assay feasibility, clinical validation) (HLAAAMAA)
Keywords
Where engine the biomarker company is headquartered
LocationHeadquarters
- HQ city
- Hennigsdorf
- HQ country
- Germany
- HQ region
- Europe
Markets served
engine the biomarker company business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Protein Array Product Sales: Sale of protein arrays (hEXselect and UniPEx) to customers who perform their own screening experiments. Arrays are priced per unit with bulk discount options available.
- Biomarker Testing Service: Full-service screening package where engine performs the analysis using customer samples. Includes array, screening service, and result compilation. Results delivered within 2 weeks.
- Custom Subarray Service: Customized subarrays generated from subsets of the human cDNA library, with sizes ranging from 500 to 13,000 clones for cost-effective candidate validation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | hEXselect Array - Full service package |
| Unit Pricing | Pay-as-you-go | UniPEx Array - Full service package |
| One time/ perpetual license | Multi-year contract | Custom Protein Array |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
engine the biomarker company product offering
Product offeringCore offering
engine the biomarker company sells high-density protein arrays (hEXselect and UniPEx) covering more than 15,000 human antigens, and provides full-service biomarker testing and antibody specificity screening where customers submit samples and receive evaluated results within two weeks. Offerings include custom subarrays, enzymatic modification for post-translational modification studies, and proprietary image analysis and annotation software.
Product overview
engine the biomarker company offers a comprehensive protein array-based biomarker discovery platform consisting of three protein array products (hEXselect, UniPEx, and Custom arrays), two service offerings (Biomarker Testing and Antibody Specificity services), and supporting software tools (Annotator and VisualPattern20). The hEXselect and UniPEx arrays provide broad proteome coverage with >15,000-21,000 human antigens for hypothesis-free biomarker screening, while Custom arrays offer targeted sub-sets for cost-effective validation. The services analyze sample interactions with these arrays and provide results within 2 weeks. Proprietary enzymatic modification capabilities enable investigation of disease-related protein modifications (citrullination, phosphorylation, carbamylation).
Differentiator
Problem solved
Functional benefit
Brands
- hEXselect Array: Human fetal brain cDNA library protein array with >57,000 spots and >21,000 distinct human antigens representing >7,000 different genes.
- UniPEx Array
Products and services
- hEXselect Protein Array
Companies that use engine the biomarker company
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
engine the biomarker company technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature6 records
engine the biomarker company partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- in.ventminorStrategic cooperation to offer a protein array kit to identify and validate biomarkers - from biospecimen to upscaling. Combines engine's protein array technology with in.vent's capabilities to provide an end-to-end biomarker identification solution.
- Austrian Institute of Technology (AIT)minorCooperation partner for validation of array-based antibody-protein interactions. Together conducted validation experiments testing rheumatoid arthritis patient sera using engine protein arrays, validated with AIT's certified immunomics workflow for screening, confirmation and validation of autoantibodies.
- RZPD (Resource Centre of the German Human Genome Project)coreTrusted origin of technology. Human fetal brain hEx1 library sourced from MPI & RZPD. RZPD was the original distribution channel for the high-density filter arrays and contributed to the establishment of the technology.
- imaGenes / Source BiosciencescoreTrusted origin of technology. Human CD4+ T-cells, lung, colon cDNA library sourced from imaGenes and Source Biosciences.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
engine the biomarker company competitors and assessment
Company assessmentDirect peers
- Olink: Olink provides proximity-extension-assay-based protein biomarker discovery platforms (Olink Explore, Olink Target) with thousands of protein targets per sample. It competes with engine in hypothesis-free biomarker screening for pharma and academic customers and represents the most capital-backed direct competitor in plasma proteomics.
- Standard BioTools (formerly SomaLogic): Standard BioTools operates the SomaScan platform, an aptamer-based proteomics assay measuring ~7,000 proteins per sample. It directly competes with engine's high-content protein arrays for pharma biomarker discovery, translational research, and population-scale proteomics studies.
- RayBiotech: RayBiotech manufactures antibody arrays and protein arrays for biomarker discovery and cytokine profiling, serving academic and pharma researchers globally. Its array-based product portfolio and CRO-style services overlap closely with engine's hEXselect, UniPEx, and biomarker testing offerings.
- Meso Scale Diagnostics (MSD): MSD provides multiplexed immunoassay platforms (e.g., U-PLEX, S-PLEX) for biomarker quantification across hundreds of analytes per sample. It competes with engine in pharma translational biomarker work and benefits from established regulatory-grade assay content.
Broad incumbents
- Bio-Techne (R&D Systems): Bio-Techne, including the R&D Systems brand, is a large life-science reagents and proteomics tools supplier offering antibody arrays, ELISA kits, and Luminex-based multiplex assays. It competes with engine across multiple array and biomarker discovery product lines within a much broader portfolio.
- Bio-Rad Laboratories: Bio-Rad supplies a broad portfolio of life-science research tools, including Bio-Plex multiplex immunoassay systems and protein arrays. It overlaps with engine in multiplex protein analysis for academic and pharma research, though Bio-Rad's offerings span a far wider instrumentation footprint.
- MilliporeSigma (Merck KGaA Life Science): MilliporeSigma, the life science arm of Merck KGaA, provides an extensive catalog of antibodies, assay kits, reagents, and lab services including proteomics offerings. As a broad incumbent, it competes with engine on protein array consumables, biomarker assay reagents, and antibody specificity tools within a global distribution network.
- Thermo Fisher Scientific: Thermo Fisher Scientific offers proteomics instruments, immunoassay kits, and biomarker discovery services through brands like Invitrogen and Pierce. As the largest life-science tools incumbent, it competes with engine across reagent, instrument, and CRO services for biomarker research.
- Abcam: Abcam supplies a deep catalog of antibodies and related reagents including knockout-validated antibodies and protein arrays. While its primary focus is antibody reagents, its offerings into antibody specificity validation overlap directly with engine's Antibody Specificity Service and custom array products.
Emerging players
- Bethyl Laboratories (part of Fortis Life Sciences): Bethyl Laboratories, now part of Fortis Life Sciences, offers high-quality antibodies and a Bethyl-Arrays protein array product. It competes with engine in array-based biomarker and antibody specificity services with a similar niche-tools positioning but a broader antibody catalog focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
engine the biomarker company social profiles
Digital presenceengine the biomarker company compliance and trust
Trust signalCompliance2 records
engine the biomarker company financial estimates
Financial estimateRevenue estimate
Valuation estimate
engine the biomarker company leadership team
Management profileNumber of profiles
engine the biomarker company funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
engine the biomarker company M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about engine the biomarker company
What does engine the biomarker company do?
engine the biomarker company sells high-density protein arrays (hEXselect and UniPEx) covering more than 15,000 human antigens, and provides full-service biomarker testing and antibody specificity screening where customers submit samples and receive evaluated results within two weeks. Offerings include custom subarrays, enzymatic modification for post-translational modification studies, and proprietary image analysis and annotation software.
Is engine the biomarker company a public or private company?
engine the biomarker company is a private company. It is classified as unknown and is currently operating.
When was engine the biomarker company founded?
engine the biomarker company was founded in 2008.
Where is engine the biomarker company based?
engine the biomarker company is headquartered in Hennigsdorf, Germany, in the Europe region.
How does engine the biomarker company make money?
Three revenue lines are on record. Protein Array Product Sales are the primary driver. The others are biomarker Testing Service and custom Subarray Service.
Who are engine the biomarker company's main competitors?
Direct peers on record are Olink, Standard BioTools (formerly SomaLogic), RayBiotech and Meso Scale Diagnostics (MSD). Broad incumbents are Bio-Techne (R&D Systems), Bio-Rad Laboratories, MilliporeSigma (Merck KGaA Life Science), Thermo Fisher Scientific and Abcam. Bethyl Laboratories (part of Fortis Life Sciences) is listed as an emerging player.
Does engine the biomarker company have an API?
No public API is recorded for engine the biomarker company.
What industry is engine the biomarker company in?
engine the biomarker company's product category is Proteomics and biomarker discovery services. Its primary akta.pro industry code is HLAAAMAA, Biomarker Discovery & Validation (omics, assay feasibility, clinical validation). Its NAICS code is 325413 and its SIC code is 2835.